Kimberly-Clark Corporation reported its fourth quarter and full-year 2024 results on January 28, 2025, demonstrating solid performance in the first year of its 'Powering Care' transformation strategy. For the full year 2024, net sales were $20.1 billion, a 1.8% decrease from the prior year, while organic sales grew 3.2%, driven by a 0.8% increase in volume and a 0.4% benefit from favorable product mix.
The company achieved a meaningful expansion in adjusted gross margin of 200 basis points to 36.5% for the full year, fueled by $745 million in gross productivity savings. Adjusted operating profit increased by 9.4% to $3.2 billion, and adjusted diluted earnings per share (EPS) rose by 11.1% to $7.30, both exceeding the company's long-term growth algorithm.
For 2025, Kimberly-Clark expects organic sales growth to outpace the weighted average growth in its categories, which are currently growing at approximately two percent. Adjusted operating profit is projected to grow at a high single-digit rate on a constant-currency basis, and adjusted EPS is expected to grow at a mid-to-high single-digit rate on a constant-currency basis, despite anticipated negative impacts from currency translation and divestitures.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.